Clinical
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections
2
FDA clears FemVue Controlled for in-office tubal assessment
3
Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more
4
Michelle Manzo, MPH, CMPP, discusses epilepsy challenges in motherhood
5